These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1926674)

  • 81. Safety and tolerance of trospium chloride in the high dose range.
    Breuel HP; Mürtz G; Bondy S; Horkulak J; Gianetti BM
    Arzneimittelforschung; 1993 Apr; 43(4):461-4. PubMed ID: 8494577
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Clinical pharmacokinetics of trospium chloride.
    Doroshyenko O; Jetter A; Odenthal KP; Fuhr U
    Clin Pharmacokinet; 2005; 44(7):701-20. PubMed ID: 15966754
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Long-term safety and efficacy of trospium chloride for the treatment of neurogenic overactive bladder due to Parkinson's disease is there an effect on cognitive status?].
    Korshunova ES; Andreev MN; Korshunov MN; Pyatnitskaya TM; Korshunov DM; Darenkov SP; Suponeva NA
    Urologiia; 2022 Dec; (6):71-77. PubMed ID: 36625617
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [High doses of trospium chloride in patients with idiopathic overactive bladder. Data of large-scale, multicenter observational program Resource].
    Krivoborodov GG; Tur EI; Efremov NS; Shkolnikov ME
    Urologiia; 2016 Aug; (4):29-34. PubMed ID: 28247723
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. Committee of the European Study Group of SUDIMS (Sexual and Urological Disorders in Multiple Sclerosis).
    Fowler CJ; van Kerrebroeck PE; Nordenbo A; Van Poppel H
    J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):986-9. PubMed ID: 1469417
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Intravesical application of oxybutynine: mode of action in controlling detrusor hyperreflexia. Preliminary results.
    Madersbacher H; Knoll M
    Eur Urol; 1995; 28(4):340-4. PubMed ID: 8575504
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Effect of trospium chloride on lower urinary tract function].
    Suzuki T; Nishizawa S; Sugaya K; Kohama T; Matsuzaki A; Fukuda T; Tsukada O; Harada T; Tsuchida M
    Nihon Heikatsukin Gakkai Zasshi; 1989 Dec; 25(6):372-5. PubMed ID: 2702295
    [No Abstract]   [Full Text] [Related]  

  • 88. Nicergoline in the treatment of neuropathic bladder dysfunction: a preliminary report.
    Gallego J; Forner V; Jimenez F; Martinez E
    Paraplegia; 1984 Aug; 22(4):216-24. PubMed ID: 6483464
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Ultrasound studies of the effect of trospium chloride on gall-bladder kinetics.
    Matzkies F; Mürtz G; Giannetti B; Lenhard G; Schicketanz KH
    Arzneimittelforschung; 1992 Dec; 42(12):1456-8. PubMed ID: 1288510
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prazosin treatment of neurological patients with detrusor hyperreflexia and bladder emptying disability.
    Petersen T; Husted SE; Sidenius P
    Scand J Urol Nephrol; 1989; 23(3):189-94. PubMed ID: 2678426
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effects of intravesical instillation of verapamil in patients with detrusor hyperactivity.
    Mattiasson A; Ekström B; Andersson KE
    J Urol; 1989 Jan; 141(1):174-7. PubMed ID: 2908945
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Trospium chloride--an effective drug in the treatment of overactive bladder and detrusor hyperreflexia.
    Höfner K; Oelke M; Machtens S; Grünewald V
    World J Urol; 2001 Nov; 19(5):336-43. PubMed ID: 11760782
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Urodynamic evaluation of the effects of metoclopramide on the function of the detrusor muscle].
    Cecchi M; Marconi A; Stomaci N; Morelli G; Cuttano MG; Minervini R; Lenzi R
    Minerva Urol Nefrol; 1988; 40(4):257-9. PubMed ID: 2472013
    [No Abstract]   [Full Text] [Related]  

  • 94. Enhancement of detrusor reflex activity by naloxone in patients with chronic neurogenic bladder dysfunction. Preliminary report.
    Vaidyanathan S; Rao MS; Chary KS; Sharma PL; Das N
    J Urol; 1981 Oct; 126(4):500-2. PubMed ID: 7288940
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Neurogenic overactive bladder: focus on cognitive function].
    Korshunova ES; Korshunov MN; Nuzhnyi EP; Zakroyshhikova IV; Zabirova AK; Korshunov DM; N SA; Darenkov SP
    Urologiia; 2021 Nov; (5):35-40. PubMed ID: 34743429
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Significance of detrusor compliance in patients with localized partial lesions of the spinal cord and cauda equina.
    Gunasekera WS; Richardson AE; Seneviratne KN; Eversden ID
    Surg Neurol; 1983 Jul; 20(1):59-62. PubMed ID: 6306853
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Urodynamic effects of oral benzilonium bromide in healthy subjects.
    Nyman CR
    Urol Int; 1981; 36(1):67-72. PubMed ID: 7257013
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Uninhibited neurogenic bladder treated with Prazosin.
    Jensen D
    Scand J Urol Nephrol; 1981; 15(3):229-33. PubMed ID: 7323743
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Effects of different drugs on the cystometrogram in conscious rats.
    Guarneri L; Cova R; Angelico P; Colli E; Testa R
    Pharmacol Res; 1991 Aug; 24(2):175-87. PubMed ID: 1749747
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Trospium chloride (Sanctura)--new to the U.S. for overactive bladder.
    Gaines KK
    Urol Nurs; 2005 Feb; 25(1):64-5, 52. PubMed ID: 15779697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.